CTNNB1 and neoplasm: When the diagnosis is restricted to neoplasms with typical features, the vast majority of primary Sertoli cell tumour NOS (>90%) show evidence of Wnt pathway activation, mostly, albeit not exclusively, by gain‐of‐function CTNNB1 exon 3 variants.53, 54